StarZero All shows Try the podcast clipper →

Biotech

2 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Nov 11, 2025 by Dave Ricks · across every show →

Everything said about Biotech, oldest first

Nov 11, 2025 neutral
Assertion Partly supported
Ricks: Over half of approved drugs originate in biotech, but few finish
“While it's true that the origin of, I think it's a little more than half of medicines approved in the last 10 years have come from biotech, hardly any of those traveled all the way through biotech.”
Dave Ricks Nov 11, 2025 ▶ 1:00:42 Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Nov 11, 2025 positive
Opinion
Ricks: Lilly conducts early clinical trials faster and cheaper than any biotech
“There is no doubt in my mind. We are faster, more robust, probably cheaper than actually every biotech out there trying to do their own early phase clinical trials.”
Dave Ricks Nov 11, 2025 ▶ 1:01:11 Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Made with StarZero

Turn any episode into a week of clips.

This entire site, about 28 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more